Clinical Trials in Europe: The Die Is Cast
The European Union's new clinical trials rules have been agreed after more than 18 months of often-acrimonious debate. The Council of Ministers signed off on the legislation on April 14. But where politicians and health campaigners are celebrating, the European drug industry is not so euphoric, writes Reflector ...Read more |
Read April’s Pharm Exec Emerging Markets Special
In this issue: Africa — factors affecting direct foreign investment in the healthcare sector; Diabetes in China — is pharma listening to social media?; HIV treatments in Russia — dynamics, challenges, recommendations; Latin America — market access for specialty products; and more ... Read more
|
Biopharmaceuticals: Approvals Rate Best in Five Years
Overall, last year can be considered quite a successful one in terms of new product approvals. Nineteen products containing new biopharmaceutical molecular entities were approved in the U.S. and/or the EU. These approval numbers are above average compared to the previous five years ... Read more
|
Fixing Wikipedia
It’s been reported that the top 25 Wikipedia healthcare pages were each accessed more that 2 million times in a 12-month period. Will pharma join a growing effort to make this leading online health information resource more relevant to providers and safer for patients? Peter Houston reports ... Read more
|
Pharm Exec’s Emerging Pharma Leaders 2014 — Nominate Now
It's time for you to tell us who you think should receive Pharm Exec's 2014 Emerging Pharma Leadership Award. Read more for details of how to nominate a colleague — or yourself ... Read more
|
|
| Sciformix |
 Scignal Plus: Taking the Noise Out of Signal Detection
Scignal Plus provides superior, efficient signal detection by incorporating computational algorithms for a new method and previously known methods of signal detection. It has several distinct and important advantages over other products that are available in the market.  Read more |
|
|
|
|
|
|
